000739 Stock Overview
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Apeloa Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.72 |
| 52 Week High | CN¥18.96 |
| 52 Week Low | CN¥10.66 |
| Beta | 0.057 |
| 11 Month Change | -3.20% |
| 3 Month Change | 5.93% |
| 1 Year Change | -7.15% |
| 33 Year Change | -60.53% |
| 5 Year Change | 14.83% |
| Change since IPO | 99.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000739 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -1.5% | -2.1% |
| 1Y | -7.1% | -9.4% | 2.8% |
Return vs Industry: 000739 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 000739 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 000739 volatility | |
|---|---|
| 000739 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000739 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000739's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 7,208 | Chun He | www.apeloa.com |
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.
Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary
| 000739 fundamental statistics | |
|---|---|
| Market cap | CN¥18.21b |
| Earnings (TTM) | CN¥1.07b |
| Revenue (TTM) | CN¥12.26b |
17.0x
P/E Ratio1.5x
P/S RatioIs 000739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000739 income statement (TTM) | |
|---|---|
| Revenue | CN¥12.26b |
| Cost of Revenue | CN¥9.44b |
| Gross Profit | CN¥2.83b |
| Other Expenses | CN¥1.75b |
| Earnings | CN¥1.07b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 23.06% |
| Net Profit Margin | 8.75% |
| Debt/Equity Ratio | 14.3% |
How did 000739 perform over the long term?
See historical performance and comparison